Segui
Serena Massari
Serena Massari
Email verificata su unipg.it
Titolo
Citata da
Citata da
Anno
A 1, 8-naphthyridone derivative targets the HIV-1 Tat-mediated transcription and potently inhibits the HIV-1 replication
S Massari, D Daelemans, ML Barreca, A Knezevich, S Sabatini, ...
Journal of medicinal chemistry 53 (2), 641-648, 2010
1582010
A broad anti-influenza hybrid small molecule that potently disrupts the interaction of polymerase acidic protein–basic protein 1 (PA-PB1) subunits
S Massari, G Nannetti, J Desantis, G Muratore, S Sabatini, G Manfroni, ...
Journal of Medicinal Chemistry 58 (9), 3830-3842, 2015
992015
Structure− activity relationship study on anti-HIV 6-desfluoroquinolones
O Tabarrini, S Massari, D Daelemans, M Stevens, G Manfroni, S Sabatini, ...
Journal of medicinal chemistry 51 (17), 5454-5458, 2008
872008
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors
A Astolfi, T Felicetti, N Iraci, G Manfroni, S Massari, D Pietrella, O Tabarrini, ...
Journal of medicinal chemistry 60 (4), 1598-1604, 2017
662017
Inhibition of subgenomic hepatitis C virus RNA replication by acridone derivatives: identification of an NS3 helicase inhibitor
G Manfroni, J Paeshuyse, S Massari, S Zanoli, B Gatto, G Maga, ...
Journal of medicinal chemistry 52 (10), 3354-3365, 2009
642009
Studies on anti-HIV quinolones: new insights on the C-6 position
S Massari, D Daelemans, G Manfroni, S Sabatini, O Tabarrini, ...
Bioorganic & medicinal chemistry 17 (2), 667-674, 2009
642009
Structural investigation of cycloheptathiophene-3-carboxamide derivatives targeting influenza virus polymerase assembly
S Massari, G Nannetti, L Goracci, L Sancineto, G Muratore, S Sabatini, ...
Journal of Medicinal Chemistry 56 (24), 10118-10131, 2013
602013
Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to …
S Sabatini, F Gosetto, N Iraci, ML Barreca, S Massari, L Sancineto, ...
Journal of medicinal chemistry 56 (12), 4975-4989, 2013
562013
Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase
G Manfroni, F Meschini, ML Barreca, P Leyssen, A Samuele, N Iraci, ...
Bioorganic & medicinal chemistry 20 (2), 866-876, 2012
532012
Polymerase acidic protein–basic protein 1 (PA–PB1) protein–protein interaction as a target for next-generation anti-influenza therapeutics
S Massari, L Goracci, J Desantis, O Tabarrini
Journal of medicinal chemistry 59 (17), 7699-7718, 2016
522016
Engagement of nuclear coactivator 7 by 3-hydroxyanthranilic acid enhances activation of aryl hydrocarbon receptor in immunoregulatory dendritic cells
M Gargaro, C Vacca, S Massari, G Scalisi, G Manni, G Mondanelli, ...
Frontiers in Immunology 10, 1973, 2019
502019
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction
T Felicetti, R Cannalire, D Pietrella, G Latacz, A Lubelska, G Manfroni, ...
Journal of medicinal chemistry 61 (17), 7827-7848, 2018
472018
Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity
J Desantis, G Nannetti, S Massari, ML Barreca, G Manfroni, V Cecchetti, ...
European Journal of Medicinal Chemistry 138, 128-139, 2017
452017
From 6-Aminoquinolone Antibacterials to 6-Amino-7-thiopyranopyridinylquinolone Ethyl Esters as Inhibitors of Staphylococcus aureus Multidrug Efflux Pumps
M Pieroni, M Dimovska, JP Brincat, S Sabatini, E Carosati, S Massari, ...
Journal of medicinal chemistry 53 (11), 4466-4480, 2010
432010
Computer‐Aided Design, Synthesis and Validation of 2‐Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti‐HIV‐1 Tat‐Mediated Transcription Activity
L Sancineto, N Iraci, S Massari, V Attanasio, G Corazza, ML Barreca, ...
ChemMedChem 8 (12), 1941-1953, 2013
402013
Structural Investigation of the Naphthyridone Scaffold: Identification of a 1, 6‐Naphthyridone Derivative with Potent and Selective Anti‐HIV Activity
O Tabarrini, S Massari, L Sancineto, D Daelemans, S Sabatini, ...
ChemMedChem 6 (7), 1249-1257, 2011
392011
Blocking HIV-1 replication by targeting the Tat-hijacked transcriptional machinery
S Massari, S Sabatini, O Tabarrini
Current pharmaceutical design 19 (10), 1860-1879, 2013
382013
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3‐Phenyl‐1,4‐benzothiazine Analogues
T Felicetti, R Cannalire, MS Burali, S Massari, G Manfroni, ML Barreca, ...
ChemMedChem 12 (16), 1293-1302, 2017
342017
Functionalized 2, 1-benzothiazine 2, 2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase
R Cannalire, D Tarantino, A Astolfi, ML Barreca, S Sabatini, S Massari, ...
European journal of medicinal chemistry 143, 1667-1676, 2018
322018
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium
R Cannalire, D Machado, T Felicetti, SS Costa, S Massari, G Manfroni, ...
European Journal of Medicinal Chemistry 140, 321-330, 2017
312017
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20